Industry Insights
SUMMARY1
The U.S. Continuous Glucose Market (CGM) is on a strong upward trajectory, with a compound annual growth rate (CAGR) of 9.5% through 2033. This represents a CAGR of 9.5% over the forecast period. Despite this impressive growth, the market remains significantly underpenetrated, with only about 25% of eligible patients currently using CGM systems. With a total addressable market estimated at over $20 billion, there is substantial room for expansion, particularly as awareness, accessibility, and innovation continue to improve.
MARKET OVERVIEW2
The CGM market in the United States is expanding rapidly, driven by the increasing prevalence of diabetes and the growing demand for real-time glucose monitoring solutions. With over 34 million Americans living with diabetes, the need for effective, continuous monitoring tools is more critical than ever. The market’s projected growth from $3.7 billion in 2024 to $8.4 billion by 2033 underscores the increasing reliance on CGMs as a standard of care for both Type 1 and Type 2 diabetes management.
KEY GROWTH DRIVERS
$ 8.4 The market’s projected growth from $3.7 billion in 2024 to $8.4 billion by 2033
Several factors are fueling the growth of the CGM market. First and foremost is the rising prevalence of diabetes. According to the CDC, more than 1.2 million Americans have Type 1 diabetes, while over 33 million are living with Type 2 diabetes. This growing patient population is driving demand for more effective and userfriendly monitoring solutions. Technological advancements are also playing a pivotal role. Innovations such as implantable sensors, extended sensor wear times, and improved accuracy are making CGMs more appealing and accessible. Additionally, expanded insurance coverage, including Medicare reimbursement, is reducing financial barriers and enabling broader adoption. Another emerging driver is the potential for CGM use in hospital settings, where continuous monitoring can improve outcomes for inpatients with diabetes.
EMERGING TRENDS
Several key trends are shaping the future of the CGM market. One of the most significant is the integration of CGMs with digital health platforms. Many devices now sync with smartphones and smartwatches, allowing users to track glucose levels in real time and share data with healthcare providers. Artificial intelligence and predictive analytics are also being incorporated to provide users with actionable insights and trend forecasts. Additionally, there is a growing emphasis on affordability and accessibility, with companies developing more cost-effective solutions to reach underserved populations. These trends are not only enhancing the user experience but also expanding the market’s reach.
MARKET OPPORTUNITIES
Looking ahead, the CGM market presents numerous opportunities for growth. The implantable CGM segment alone is expected to reach a $5 billion market in North America and Europe by 2035, driven by innovations in sensor longevity and convenience. Perhaps most notably, the non-insulin-dependent Type 2 diabetes population remains largely untapped, representing a significant growth frontier for CGM technologies.
KEY TAKEAWAYS
The U.S. CGM market is entering a period of robust expansion, supported by technological innovation, favorable policy changes, and increasing demand for better diabetes management tools. As the market continues to evolve, the focus will be on improving user experience, expanding access, and integrating CGMs into broader healthcare ecosystems. With a large addressable market and strong momentum, CGMs are set to become a cornerstone of modern diabetes care in the years ahead.
VGM Industry Insights provides data-driven analysis and trends within the durable medical equipment, prosthetics, orthotics, and supplies (DMEPOS) sector. Our focus areas include market trends, innovation, and strategic decision-making, helping stakeholders stay informed and competitive. We are committed to a forward-thinking approach, continuously monitoring industry developments to drive progress and innovation.
ALAN MORRIS SVP of Strategy
TYLER COULANDER Market Strategy Manager
